DONALD F. KLEIN EARLY CAREER INVESTIGATOR AWARD
Deadline: October 1
This award will be given to an early career investigator for the best original research paper on neurobiology, psychopharmacology, psychosocial treatments, or experimental psychopathology of anxiety and anxiety-related disorders. The winning paper will be presented at the ADAA Annual Conference followed by rapid publication in ADAA’s official journal, Depression and Anxiety. The award will be presented by Donald Klein, MD, at the 30th Annual Conference, March 4-7, 2010, at the Baltimore Marriott Waterfront.

Eligibility
The award is restricted to investigators who have completed their terminal degree and are currently at a rank of assistant professor or below. Individuals who are currently working to complete their degree are not eligible. Applicants must be the first or senior author on the submitted paper. The paper must be original research on anxiety and anxiety-related disorders focusing on neurobiology, psychosocial treatments, or experimental psychopathology. Applicants must be members of ADAA, but we welcome new members, so interested non-members should feel free to join and then submit.

How to Apply
Submissions should be sent to ADAA, in English, following the author instructions for Depression & Anxiety at www3.interscience.wiley.com/journal/38924/home/ForAuthors.html. Word limits for this award are extended to 4,000 for original research.

Applicants must also complete the one-page application form and submit the form and manuscript together electronically to awards@adaa.org before the deadline. Manuscripts will be reviewed by members of ADAA’s Scientific Advisory Board. Call 240-485-1001 with questions.

Award Details
The winner will receive a $1,000 award, up to $1,000 to help defray expenses to the conference, and complimentary registration to the 30th Annual Conference. The winner will be assigned a mentor from the ADAA Scientific Advisory Board. The award recipient will be expected to make an oral presentation at the conference. The research paper will be published in Depression and Anxiety. The winner will be invited to participate on the selection committee for the 2011 award. 

This award is named after Donald F. Klein, MD, who revolutionized psychiatric thinking through his discovery in the early ’60s that imipramine, a recently developed psychotropic medication, was effective in blocking panic attacks. Dr. Klein observed that patients with panic attacks were suffering from a distinct disease entity, which was ultimately referred to as panic disorder. Dr. Klein’s early contribution to the development of the DSM in large part gave birth to the modern branch of medical science dealing with the classification of disease of anxiety disorders. He dissected out a schema for diagnosing anxiety disorders that is routinely used to this day. He separated panic disorder and agoraphobia from generalized anxiety disorder, social phobia, and simple phobia. Dr. Klein’s early findings also heralded in the era of childhood anxiety disorders as biochemical disorders when he discovered that imipramine blocked childhood separation anxiety disorders. In later years, Dr. Klein developed a compelling evolutionary-based hypothesis accounting for the etiology of panic disorders, which terms “the false suffocation alarm theory of panic disorders.” His work continues to remain relevant and topical to the present. Dr. Klein was the recipient of ADAA’s first Lifetime Achievement Award in 2005.

The Donald F. Klein Early Career Investigator Award is supported by Depression and Anxiety, the official journal of ADAA, published by Wiley-Blackwell, the scientific, technical, medical, and scholarly business of John Wiley & Sons, Inc.